Date Received04/03/2017
Responses with Offer to Supply04/17/2017
Rebuttal to Responses with Offer to Supply04/21/2017
Projected Completion Date05/15/2017
Company NameST&RforMedline
ProductTwo-way Stretch Polyester/Rayon/Spandex Twill weave fabric

HTS: 5515.11.00

Fiber Content: 69-75% polyester; 20-26% rayon, 2-8% spandex

Warp: plied polyester/rayon staple with spandex filament

Filling: plied textured polyester filament with spandex filament

Thread count: 120-130 warp ends per liniear inch (47.2-51.2 warp ends per linear cm); 90-100 filling ends per linear inch (35.43 - 39.37 filling ends per linear cm).

Fabric weight: 194 to 206 grams per meter squared (5.7 to 6.1 ounces per square yard).

Finishing process: Softened

Coloration: piece dyed, yarn dyed, bleached and printed.

Performance Criteria:

Dimensional Stability/Shrinkage (AATCC 135): +/- 3%

Colorfastness to Laundering (AATCC 61): >/= 4.0 color change; >/= 3.5 staining for light colors (3.0 for dark colors)

Colorfastness to Crocking (AATCC 8): >/= 4.0 dry; >/= 3 wet for light colors (2.5 for dark colors).

NOTE: The yarn size designations describe a range of yarn specifications for yarn before knitting, dyeing and finishing of the fabric. They are intendd as specifications to be followed by the mill in sourcing yarn used to produce the fabric. Dyeing, finishing and knitting can alter the characteristic of the yarn as it appears in the finished fabric. This specification therefore includes yarn sizes provided that the variation occurs after processing of the greige yarn and production of the fabric. The specifications for the fabric apply to the fabric itself prior to cutting and sewing of the finished garment. Such processing may alter the measurements.
Quantity Requested
Fabric, Fiber, or Yarn?Fabric
ContactDybczak- Maria
File Number209.2017.04.03.Fabric.ST&RforMedline
Commercial Availability Request:

FINAL Medline Short Supply Request 2017-03-31 PUBLIC.pdfFINAL Medline Short Supply Request 2017-03-31 PUBLIC.pdfMedline Due Dilignece Certificate 3-29.pdfMedline Due Dilignece Certificate 3-29.pdfSTR Due Diligence Certificate.pdfSTR Due Diligence Certificate.pdfFR_2017-09430.pdf


Rebuttals to Responses:

Meeting Notice:

Determination: Approved – Add product to Annex 3.25